What clinical trials are available at UCSF for Parkinsons disease, and what are the advantages of participating in them?
We have recently completed enrollment of a 316-patient, 6 single-center trial of GPi versus STN DBS for Parkinson’s disease, and we continue to collect data on those patients. We have completed a phase II, 8-center trial of gene transfer, introducing a gene encoding a growth factor, for Parkinson’s disease. We have ongoing trials to study new DBS devices, new technical approaches to DBS including use of interventional MRI, and brain physiology in movement disorders.